Drug intelligence / Profile preview

STA

Development stage: Preclinical
Lead developer: Peaches Biotech

Overview

STA (Transfer and Nesting Solution) is a biological solution developed by Peaches Biotech designed to support tissue regeneration. It functions as a specialized medium intended to provide a supportive microenvironment or scaffold that facilitates the delivery, survival, and integration ("nesting") of therapeutic cells or tissues at a target site. By optimizing the conditions for cellular integration and functional recovery, STA aims to enhance the overall efficacy of regenerative medicine procedures. The product is currently in the preclinical stage of development for general tissue regeneration applications.

Other names: Transfer and Nesting SolutionSolución de Transferencia y AnidamientoSTA solution

Beyond the preview

Go deeper on STA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on STA.

Explore the full profile